Drug details

Integrilin (eptifibatide)

type of Glycoprotein IIb/IIIa Inhibitors

Integrilin (eptifibatide) injection is a platelet aggregation inhibitor indicated for treatment of acute coronary syndrome (ACS) managed medically or with percutaneous coronary intervention (PCI), and treatment of patients undergoing PCI (including intracoronary stenting). Integrilin injection is available in generic form.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• lightheadedness,
• bloody or tarry stools,
• any bleeding that will not stop,
• coughing up blood, and
• vomit that looks like coffee grounds
• red or pink urine,

The following drugs are related to Integrilin, either as a replacement or used together:

• Altoprev (lovastatin extended-release tablets)
• Arixtra (fondaparinux sodium)
• Cardene I.V. (nicardipine hydrochloride)
• Cardene SR (nicardipine hydrochloride sustained release capsules)
• Coreg (carvedilol)
• Coreg CR (carvedilol phosphate extended-release)
• Crestor (rosuvastatin calcium)
• Iprivask (desirudin for injection)
• Tiazac (diltiazem hcl)
• Lovenox (enoxaparin sodium injection)
• Integrilin (etifibatide) Injection (etifibatide injection)
• InnoPran XL (propranolol hydrochloride)
• Mevacor (lovastatin)
• Lovaza (omega-3-acid ethyl esters)